4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2020 / Meta-analysis of prospective cohort studies
A meta-analysis evaluated 20 prospective cohort studies assessing potato consumption and mortality risk. No significant associations were observed for all-cause mortality (0.90, 95% CI: 0.80 to 1.02, p = 0.096; 25,208 cases) or cancer mortality (1.09, 95% CI: 0.96 to 1.24, P = 0.204; 4,877 cases). Among three studies examining cardiovascular mortality (2,366 cases), two found no significant relationship.
Shows an association, not proof of cause and effect.
Darooghegi Mofrad M, Milajerdi A, Sheikhi A, et al. Crit Rev Food Sci Nutr, 2020. PMID 30638040
2020 / Systematic review and dose-response meta-analysis
A meta-analysis analyzed 8 studies comprising 11,750 individuals and 6,176 hypertensive cases. High circulating TMAO levels were associated with greater hypertension prevalence compared to low levels (RR: 1.12; 95% CI: 1.06, 1.17; P < 0.0001). In dose-response models, the relative risk of hypertension rose by 9% for each 5-μmol/L rise (RR: 1.09; 95% CI: 1.05, 1.14) and 20% for each 10-μmol/L rise in blood TMAO (RR: 1.20; 95% CI: 1.11, 1.30).
Ge X, Zheng L, Zhuang R, et al. Adv Nutr, 2020. PMID 31269204
2020 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis summarized findings from randomized controlled trials examining regular dietary olive oil consumption. Olive oil intake reduced levels of inflammatory markers, particularly interleukin-6, C-reactive protein, and tumor necrosis factor-alpha. The authors noted that additional research comparing olive oil to other dietary fats is still needed, accounting for varying daily dosages and intervention durations.
NANO counterpoint →
Fernandes J, Fialho M, Santos R, et al. Nutrition, 2020. PMID 31539817
2020 / Meta-analysis of interventional studies
A meta-analysis evaluated six interventional studies involving 317 patients with type 2 diabetes mellitus to assess glycemic control. Vinegar consumption significantly improved fasting blood glucose and hemoglobin A1c levels. Secondary outcomes revealed reductions in total cholesterol and low-density lipoprotein. The authors noted that sample sizes were relatively small and vinegar formulations varied.
Cheng LJ, Jiang Y, Wu VX, et al. J Adv Nurs, 2020. PMID 31667860
2020 / Systematic review and meta-analysis of RCTs
A meta-analysis of 32 randomised controlled trials evaluated dietary anthocyanins on inflammatory markers. Anthocyanin supplementation significantly reduced C-reactive protein (-0.33 mg/l, 95% CI: -0.55 to -0.11), IL-6 (-0.41 ρg/ml, 95% CI: -0.70 to -0.13), TNF-α (-0.64 ρg/ml, 95% CI: -1.18 to -0.09), ICAM-1 (-52.4 ng/ml, 95% CI: -85.7 to -19.1), and VCAM-1 (-49.6 ng/ml, 95% CI: -72.7 to -26.5), while increasing adiponectin (0.75 μg/ml, 95% CI: 0.23 to 1.26). Interleukin-1β and P-selectin did not significantly change.
Fallah AA, Sarmast E, Fatehi P, et al. Food Chem Toxicol, 2020. PMID 31669599
2020 / Prospective cohort and meta-analysis of prospective cohorts
In the Rotterdam Study (7,786 participants, median follow-up 13.0 years, 3,589 deaths), higher total protein intake was associated with greater all-cause mortality (HR 1.12, 95% CI 1.01-1.25), largely driven by animal protein and CVD deaths. A meta-analysis of 11 cohorts (350,452 participants, 64,306 deaths) confirmed higher all-cause mortality with total protein (pooled RR 1.05, 95% CI 1.01-1.10). Plant protein was associated with reduced all-cause (RR 0.93, 95% CI 0.87-0.99) and CVD mortality (RR 0.86, 95% CI 0.73-1.00).
Shows an association, not proof of cause and effect.
Chen Z, Glisic M, Song M, et al. Eur J Epidemiol, 2020. PMID 32076944
2020 / Meta-analysis of randomized controlled trials
A meta-analysis of 16 randomized controlled trials with 572 participants evaluated the effects of pomegranate supplementation compared to placebo. Pomegranate intake significantly lowered hs-CRP (WMD: -6.57 mg/L, 95% CI: -10.04 to -3.10), IL-6 (WMD: -1.68 pg/mL, 95% CI: -3.52 to 0.157), and TNF-alpha (WMD: -2.37 pg/mL, 95% CI: -3.67 to -1.07). However, no significant effects were observed for CRP, E-selectin, ICAM, VCAM, or MDA.
Wang P, Zhang Q, Hou H, et al. Complement Ther Med, 2020. PMID 32147056
2020 / Cohort study and meta-analysis of prospective cohort studies
In an NHANES cohort of 24,856 participants (mean follow-up 6.4 years, 3,433 deaths), higher potato consumption was initially associated with higher risks of total (42%), CVD (65%), cerebrovascular (26%), and cancer (52%) mortality (p < 0.001), but these associations disappeared after adjustment for confounding factors. In a pooled meta-analysis of prospective studies (98,569 participants), potato intake showed no significant association with total (RR = 1.25, 95% CI 0.98-1.60), CVD (RR = 0.99, 95% CI 0.90-1.08), or stroke mortality (RR = 0.94, 95% CI 0.85-1.03). However, individuals with higher potato intake displayed less favorable cardiometabolic profiles, including higher waist circumference (97.2 vs. 99.5 cm) and worse blood pressure, triglycerides, HDL-C, and TG/HDL-C ratio (all p < 0.001).
Shows an association, not proof of cause and effect.
Mazidi M, Katsiki N, Mikhailidis DP, et al. Arch Med Sci, 2020. PMID 32190135
2020 / Meta-analysis of prospective cohorts
A meta-analysis of 12 cohort studies examined dietary protein intake and mortality. Higher plant protein intake was associated with lower all-cause mortality (RR 0.92, 95% CI: 0.88 to 0.96 for highest versus lowest; RR 0.97, 95% CI: 0.94 to 0.99 per 3% increment) and may be associated with reduced cardiovascular mortality (RR 0.90, 95% CI: 0.80 to 1.01). Higher animal protein intake was possibly linked to greater cardiovascular death risk (RR 1.11, 95% CI: 1.01 to 1.22). Total protein showed no clear association with mortality.
Shows an association, not proof of cause and effect.
Qi XX, Shen P Nutr Metab Cardiovasc Dis, 2020. PMID 32451273
2019 / Systematic review and dose-response meta-analysis of prospective studies
In a meta-analysis of 123 prospective reports, higher intakes of whole grains, fruits, vegetables, and fish were linked to reduced risks of coronary heart disease, stroke, or heart failure. Red meat, processed meat, and sugary drinks were associated with higher risks across all three conditions. Higher egg intake was specifically associated with increased heart failure risk (RR 1.16, 95% CI: 1.03-1.31).
Shows an association, not proof of cause and effect.
NANO counterpoint →
Bechthold A, Boeing H, Schwedhelm C, et al. Crit Rev Food Sci Nutr, 2019. PMID 29039970
2019 / Systematic review and meta-analysis
A meta-analysis of 16 observational studies with 261,732 adults evaluated dietary sodium, sodium-to-potassium ratio, and stroke risk. Each 1 g/d increase in dietary sodium was associated with higher stroke risk (RR 1.06, 95% CI 1.02 to 1.10; 14 studies), and each one-unit increase in sodium-to-potassium ratio showed an elevated risk (RR 1.22, 95% CI 1.04 to 1.41; 5 studies). Linear dose-response associations were observed without evidence of a J- or U-shaped curve.
Jayedi A, Ghomashi F, Zargar MS, et al. Clin Nutr, 2019. PMID 29907351
2019 / Systematic review and meta-analysis of observational studies
Researchers analyzed 28 reports examining potato intake and chronic disease risks. Total potato consumption showed no associations with all-cause mortality (RR 0.88, 95% CI 0.69-1.12), coronary heart disease, stroke, or colorectal cancer per 150 g/day increase. Conversely, each 150 g/day increase in French fries intake was linked to higher risks of type 2 diabetes (RR 1.66, 95% CI 1.43-1.94) and hypertension (RR 1.37, 95% CI 1.15-1.63), based on mostly low- to moderate-certainty evidence.
Shows an association, not proof of cause and effect.
Schwingshackl L, Schwedhelm C, Hoffmann G, et al. Eur J Nutr, 2019. PMID 29987352
2019 / Systematic review and meta-analysis
A systematic review and meta-analysis of 33 studies evaluated the effects of garlic compared with placebo in 1,273 individuals with diabetes. Garlic was associated with significant decreases in total cholesterol by 16.87 mg/dl (95% CI, -21.01 to -12.73; P=0.001), LDL by 9.65 mg/dl (95% CI, -15.07 to -4.23; P=0.001), triglycerides by 12.44 mg/dl (95% CI, -18.19 to -6.69; P=0.001), fasting blood sugar by 10.90 mg/dl (95% CI, -16.40 to -5.40; P=0.001), and HbA1C by 0.60 mg/dl (95% CI, -0.98 to -0.22; P=0.001). Serum HDL significantly increased by 3.19 mg/dl (95% CI, 1.85 to 4.53; P=0.001).
Shabani E, Sayemiri K, Mohammadpour M Prim Care Diabetes, 2019. PMID 30049636
2019 / Systematic reviews and meta-analyses of prospective cohorts and trials
Researchers analyzed 185 prospective studies and 58 clinical trials examining carbohydrate quality markers. Observational data suggested a 15-30% decrease in all-cause and cardiovascular mortality, coronary heart disease, stroke, type 2 diabetes, and colorectal cancer when comparing highest versus lowest dietary fiber consumers. Clinical trials showed significantly lower bodyweight, systolic blood pressure, and total cholesterol with higher dietary fiber intakes. Similar findings were observed for whole grains, whereas evidence for low glycemic index or load showed smaller or no risk reductions.
Reynolds A, Mann J, Cummings J, et al. Lancet, 2019. PMID 30638909
2019 / Umbrella review of observational studies
An umbrella review examined quantitative syntheses of observational studies linking produce intake with health outcomes. Probable evidence was observed for cardiovascular protection, while possible evidence indicated lower risks of colon malignancies, depressive disorders, and pancreatic ailments for fruits. For vegetable consumption, possible evidence supported lower risks of stroke, hip fractures, colorectal malignancies, depression, and pancreatic conditions, though geographical location and sex were potential confounding factors.
Shows an association, not proof of cause and effect.
Angelino D, Godos J, Ghelfi F, et al. Int J Food Sci Nutr, 2019. PMID 30764679
2019 / Pooled analysis of 6 prospective cohort studies
Individual participant data from 6 prospective US cohorts were pooled across a median follow-up of 17.5 years, identifying 5,400 incident CVD events and 6,132 all-cause deaths. Each additional 300 mg of dietary cholesterol per day was associated with higher risks of incident CVD (adjusted HR, 1.17 [95% CI, 1.09-1.26]) and all-cause mortality (adjusted HR, 1.18 [95% CI, 1.10-1.26]). Similarly, each additional half an egg per day was linked to higher risk of incident CVD (adjusted HR, 1.06 [95% CI, 1.03-1.10]) and all-cause mortality (adjusted HR, 1.08 [95% CI, 1.04-1.11]). However, the associations for egg consumption were no longer significant after adjusting for dietary cholesterol intake.
Shows an association, not proof of cause and effect.
Zhong VW, Van Horn L, Cornelis MC, et al. JAMA, 2019. PMID 30874756
2019 / Meta-analysis of randomized controlled trials
A meta-analysis of 36 randomized controlled trials including 1,803 participants evaluated the effect of red meat against alternative diets on cardiovascular risk markers. Across all comparisons combined, red meat showed no significant differences for blood pressure, apolipoproteins, or cholesterol, though it reduced triglycerides less (WMD 0.065 mmol/L; 95% CI, 0.000 to 0.129). Replacing red meat with high-quality plant proteins yielded greater reductions in total cholesterol (WMD 0.264 mmol/L) and LDL cholesterol (WMD 0.198 mmol/L).
Guasch-Ferré M, Satija A, Blondin SA, et al. Circulation, 2019. PMID 30958719
2019 / Prospective cohort study and meta-analysis of prospective cohort studies
Researchers examined the link between low-carbohydrate diet (LCD) scores and mortality using NHANES (1999-2010) data and a pooled analysis of nine prospective cohort studies. In NHANES (24,825 participants), those in the lowest carbohydrate quartile had the highest risk of overall (32%), CVD (50%), cerebrovascular (51%), and cancer (36%) mortality compared to the highest carbohydrate intake quartile. In the pooled analysis of nine cohorts (462,934 participants), LCD was associated with higher overall (RR 1.22, 95% CI 1.06-1.39), CVD (RR 1.13, 95% CI 1.02-1.24), and cancer mortality (RR 1.08, 95% CI 1.01-1.14). The authors noted that causality cannot be proven and residual bias cannot be ruled out.
Shows an association, not proof of cause and effect.
Mazidi M, Katsiki N, Mikhailidis DP, et al. Eur Heart J, 2019. PMID 31004146
2019 / Systematic review of controlled studies
A systematic review evaluated the health promotion effects of immersive nature-experiences across 133 controlled studies. Positive effects were reported for psychological wellbeing (≈55% positive of n=97), psychosocial function (≈61% positive of n=67), psychophysiological stress response (≈58% positive of n=50), cognitive performance (≈58% positive of n=36), and social skills and relationships (≈70% positive of n=34). Findings for physical health, such as cardiovascular disease risk, were less consistent (≈37% positive, ≈28% mixed, ≈35% non-significant of n=51). Across interventions and outcomes, the overall quality of the evidence was deemed low and occasionally moderate.
Mygind L, Kjeldsted E, Hartmeyer RD, et al. Front Psychol, 2019. PMID 31130890
2019 / Umbrella review of meta-analyses of observational studies
An umbrella review examined 96 meta-analyses covering 40 unique health outcomes to assess associations with tea consumption. An increment of two to three cups per day was associated with reduced risks of total mortality, cardiac death, coronary artery disease, stroke, and type 2 diabetes mellitus, alongside beneficial associations for several cancers, skeletal, cognitive, and maternal outcomes. Harmful associations were identified for esophageal and gastric cancer when tea was consumed at temperatures above 55-60 °C. The authors state that randomized controlled trials are needed to determine causality.
Shows an association, not proof of cause and effect.
Yi M, Wu X, Zhuang W, et al. Mol Nutr Food Res, 2019. PMID 31216091
2019 / Cumulative meta-analysis of randomized controlled trials
In a cumulative meta-analysis of 46 randomized controlled trials evaluated by the FDA, soy consumption consistently lowered blood lipids over 14 years. For LDL cholesterol, average decreases were -6.3 mg/dL (95% CI: -8.7 to -3.9 mg/dL; P=0.00001) in 1999 and subsequently spanned -4.2 to -6.7 mg/dL (P=0.0006 to P=0.0002). Total cholesterol reductions also preserved statistical significance across all evaluated time points.
Jenkins DJA, Blanco Mejia S, Chiavaroli L, et al. J Am Heart Assoc, 2019. PMID 31242779
2019 / Meta-analysis of prospective cohorts
A meta-analysis evaluated 23 prospective cohorts involving 330,826 participants. Intake of soy products was inversely associated with cancer mortality (RR 0.88, 95% CI 0.79 to 0.99) and cardiovascular mortality (ES 0.85, 95% CI 0.72 to 0.99). Additionally, each 10-mg daily increment of soy isoflavones was linked to lower risk of death from all cancers and breast cancer, while soy protein was not tied to all-cause mortality.
Shows an association, not proof of cause and effect.
Nachvak SM, Moradi S, Anjom-Shoae J, et al. J Acad Nutr Diet, 2019. PMID 31278047
2019 / Meta-analysis of prospective cohorts
A meta-analysis of 19 prospective cohort studies examined total and specific nut consumption in relation to cardiovascular outcomes. Comparing highest with lowest intake categories, total nuts were inversely associated with cardiovascular incidence (RR 0.85; 95% CI 0.80-0.91) and mortality (RR 0.77; 95% CI 0.72-0.82), alongside coronary heart disease, stroke mortality, and atrial fibrillation. No significant associations appeared for stroke incidence or heart failure, and evidence certainty ranged from moderate to very low.
Shows an association, not proof of cause and effect.
Becerra-Tomás N, Paz-Graniel I, W C Kendall C, et al. Nutr Rev, 2019. PMID 31361320
2019 / Systematic review and meta-analysis of cohort studies
A meta-analysis evaluated 61 articles detailing 55 cohorts with over 4 million adults. Low-certainty evidence linked a reduction of 3 servings per week of unprocessed red meat to very small risk reductions in cardiovascular mortality, stroke, myocardial infarction, and type 2 diabetes. A 3-serving weekly reduction in processed meat was similarly linked to very small risk reductions for all-cause mortality, cardiovascular mortality, stroke, myocardial infarction, and type 2 diabetes.
Shows an association, not proof of cause and effect.
Zeraatkar D, Han MA, Guyatt GH, et al. Ann Intern Med, 2019. PMID 31569213